Genesis Drug Discovery & Development (GD3) Acquires JSS Medical Research
May 10, 2023
Genesis Drug Discovery & Development (GD3), a member of Genesis Global Group (GGG), has acquired Montreal-headquartered JSS Medical Research to expand GD3's clinical services and create a more vertically integrated drug research and development platform. The acquisition adds JSS's clinical trial management, biostatistics, data management, medical writing and safety services to GD3/GGG's existing discovery and development capabilities, supporting broader geographic reach and enhanced end-to-end offerings for pharmaceutical, biotechnology and medical device clients.
- Buyers
- Genesis Drug Discovery & Development (GD3), Genesis Global Group (GGG)
- Targets
- JSS Medical Research
- Industry
- Healthcare Services
- Location
- Quebec, Canada
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Genesis Drug Discovery & Development Acquires Comparative Biosciences (CBI)
August 5, 2020
Biotechnology
Genesis Drug Discovery & Development (GD3), a member of Genesis Biotechnology Group (GBG), has acquired Comparative Biosciences, Inc. (CBI), a Sunnyvale-based preclinical CRO. The acquisition adds GLP toxicology and safety pharmacology capabilities to GD3/GBG's integrated preclinical services, enabling end-to-end IND-enabling studies and expanding GD3's service offering.
-
GHO Capital Acquires Genesis Research
November 16, 2021
Healthcare Services
London-based GHO Capital Partners has acquired Genesis Research, a Hoboken, New Jersey–headquartered provider of tech-enabled Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) services. The transaction, which follows a prior recapitalization by Rallyday Partners, gives Genesis additional capital and European market expertise to pursue global expansion and adjacent capability growth.
-
GMSS Holdings Acquires DDP Medical Supply
September 30, 2024
Healthcare Services
GMSS Holdings, parent of Geriatric Medical & Surgical Supply, has acquired DDP Medical Supply, a national distributor of medical and diabetic supplies headquartered in St. Petersburg, Florida. The deal expands GMSS's distribution footprint and service offerings across chronic, post-acute, and home care providers while preserving both companies' brands.
-
Genesee Scientific Acquires Jade Scientific
September 15, 2025
Healthcare Services
Genesee Scientific, a portfolio company backed by LLR Partners, has acquired Jade Scientific, a Michigan-based distributor of chemicals and consumables for clinical reference, pharma/biotech, and environmental labs. The add-on expands Genesee’s lab essentials portfolio, broadening product offerings and strengthening service capabilities for customers nationwide.
-
SSI Strategy Acquires NDA Group AB
August 15, 2023
Healthcare Services
SSI Strategy has entered into a definitive agreement to acquire NDA Group AB, a regulatory affairs and drug development consultancy, to create an integrated life sciences consultancy offering end-to-end drug development and regulatory services. The combination, supported by SSI's private equity partner Amulet Capital Partners, expands SSI's regulatory capabilities and geographic footprint across the U.S. and Europe.
-
Alliance Pharma (Ampersand-backed) Acquires LGC's Drug Development Solutions; KKR Joins as Equal Shareholder
May 17, 2022
Healthcare Services
Alliance Pharma, an Ampersand-backed US bioanalytical CRO, acquired Drug Development Solutions (DDS), LGC’s UK-based bioanalytical and materials science testing business. Ampersand Capital Partners and KKR will be equal shareholders in the combined business to expand geographic reach, broaden laboratory capabilities, and extend the service portfolio internationally.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.